A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy.

Heung T Kim; Ji-Youn Han; Dae H Lee; Jong H Chun; Hong G Lee; Jae J Lee; Hyae Y Kim; Sung Y Lee; Jin S Lee

doi:10.1002/cncr.22063

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy.

Identifier:nobleid.org/w1/20260515/42ABB2FE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/42ABB2FE.svg?ark=w1%2F20260515%2F42ABB2FE)](https://nobleid.org/work/w1/20260515/42ABB2FE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy.

Identifier:nobleid.org/w1/20260515/42ABB2FE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/42ABB2FE.svg?ark=w1%2F20260515%2F42ABB2FE)](https://nobleid.org/work/w1/20260515/42ABB2FE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work